NDC properties for "0.8 ML Yuflyma 100 MG/ML Prefilled Syringe" (RxCUI 2668486)
About this data
The tables show NDC propoerties for 0.8 ML Yuflyma 100 MG/ML Prefilled Syringe with the RxCUI 2668486
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for 0.8 ML Yuflyma 100 MG/ML Prefilled Syringe (RxCUI 2668486)
| BLA | BLA761219 |
|---|---|
| RxCUI | 2668486 |
| SPL_SET_ID | 526d626f-8c9f-496c-b838-00a73bb36383 |
| Prescribable Synonym | Yuflyma 80 MG in 0.8 ML Prefilled Syringe |
| RXNAV_STR | 0.8 ML Yuflyma 100 MG/ML Prefilled Syringe |
| RxNorm Name | 0.8 ML adalimumab-aaty 100 MG/ML Prefilled Syringe [Yuflyma] |
| RxNorm Synonym | 0.8 ML Yuflyma 100 MG/ML Prefilled Syringe |
| RxNorm Synonym | Yuflyma 80 MG per 0.8 ML Prefilled Syringe |
| Related queries | Interactions (for RxCUI 2668486) |
NDC Properties
NDC Item 72606002301
| NDC 9 | 72606-023 |
|---|---|
| NDC 10 | 72606-023-01 |
| NDC Item | 72606002301 |
| Packaging | 1 SYRINGE, GLASS in 1 CARTON (72606-023-01) / .8 mL in 1 SYRINGE, GLASS |
| BLA | BLA761219 |
| FDA SPL set id | 759969 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-09-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-023 |
NDC Item 72606002302
| NDC 9 | 72606-023 |
|---|---|
| NDC 10 | 72606-023-02 |
| NDC Item | 72606002302 |
| Packaging | 1 SYRINGE, GLASS in 1 CARTON (72606-023-02) / .8 mL in 1 SYRINGE, GLASS |
| BLA | BLA761219 |
| FDA SPL set id | 759969 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-09-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-023 |
NDC Item 72606002303
| NDC 9 | 72606-023 |
|---|---|
| NDC 10 | 72606-023-03 |
| NDC Item | 72606002303 |
| Packaging | 2 SYRINGE, GLASS in 1 CARTON (72606-023-03) / .8 mL in 1 SYRINGE, GLASS |
| BLA | BLA761219 |
| FDA SPL set id | 759969 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-09-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-023 |
NDC Item 72606002301
| NDC 9 | 72606-023 |
|---|---|
| NDC 10 | 72606-023-01 |
| NDC Item | 72606002301 |
| Packaging | 1 SYRINGE, GLASS in 1 CARTON (72606-023-01) / .8 mL in 1 SYRINGE, GLASS |
| BLA | BLA761219 |
| FDA SPL set id | 759969 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-09-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-023 |
NDC Item 72606002302
| NDC 9 | 72606-023 |
|---|---|
| NDC 10 | 72606-023-02 |
| NDC Item | 72606002302 |
| Packaging | 1 SYRINGE, GLASS in 1 CARTON (72606-023-02) / .8 mL in 1 SYRINGE, GLASS |
| BLA | BLA761219 |
| FDA SPL set id | 759969 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-09-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-023 |
NDC Item 72606002303
| NDC 9 | 72606-023 |
|---|---|
| NDC 10 | 72606-023-03 |
| NDC Item | 72606002303 |
| Packaging | 2 SYRINGE, GLASS in 1 CARTON (72606-023-03) / .8 mL in 1 SYRINGE, GLASS |
| BLA | BLA761219 |
| FDA SPL set id | 759969 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-09-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-023 |
NDC Item 72606002301
| NDC 9 | 72606-023 |
|---|---|
| NDC 10 | 72606-023-01 |
| NDC Item | 72606002301 |
| Packaging | 1 SYRINGE, GLASS in 1 CARTON (72606-023-01) / .8 mL in 1 SYRINGE, GLASS |
| BLA | BLA761219 |
| FDA SPL set id | 759969 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-09-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-023 |
NDC Item 72606002302
| NDC 9 | 72606-023 |
|---|---|
| NDC 10 | 72606-023-02 |
| NDC Item | 72606002302 |
| Packaging | 1 SYRINGE, GLASS in 1 CARTON (72606-023-02) / .8 mL in 1 SYRINGE, GLASS |
| BLA | BLA761219 |
| FDA SPL set id | 759969 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-09-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-023 |
NDC Item 72606002303
| NDC 9 | 72606-023 |
|---|---|
| NDC 10 | 72606-023-03 |
| NDC Item | 72606002303 |
| Packaging | 2 SYRINGE, GLASS in 1 CARTON (72606-023-03) / .8 mL in 1 SYRINGE, GLASS |
| BLA | BLA761219 |
| FDA SPL set id | 759969 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-09-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-023 |